Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis

Shared mechanistic and phenotypic traits suggest overlapping disease mechanisms

Francisco Paulin, Tracy J. Doyle, Elaine A. Fletcher, Dana Ascherman, Ivan O. Rosas

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The prevalence of clinically evident interstitial lung disease in patients with rheumatoid arthritis is approximately 10%. An additional 33% of undiagnosed patients have interstitial lung abnormalities that can be detected with high-resolution computed tomography. Rheumatoid arthritis-interstitial lung disease patients have three times the risk of death compared to those with rheumatoid arthritis occurring in the absence of interstitial lung disease, and the mortality related to interstitial lung disease is rising. Rheumatoid arthritis-interstitial lung disease is most commonly classified as the usual interstitial pneumonia pattern, overlapping mechanistically and phenotypically with idiopathic pulmonary fibrosis, but can occur in a non-usual interstitial pneumonia pattern, mainly nonspecific interstitial pneumonia. Based on this, we propose two possible pathways to explain the coexistence of rheumatoid arthritis and interstitial lung disease: (i) Rheumatoid arthritis-interstitial lung disease with a non-usual interstitial pneumonia pattern may come about when an immune response against citrullinated peptides taking place in another site (e.g. the joints) subsequently affects the lungs; (ii) Rheumatoid arthritis-interstitial lung disease with a usual interstitial pneumonia pattern may represent a disease process in which idiopathic pulmonary fibrosis-like pathology triggers an immune response against citrullinated proteins that promotes articular disease indicative of rheumatoid arthritis. More studies focused on elucidating the basic mechanisms leading to different sub-phenotypes of rheumatoid arthritis-interstitial lung disease and the overlap with idiopathic pulmonary fibrosis are necessary to improve our understanding of the disease process and to define new therapeutic targets.

Original languageEnglish (US)
Pages (from-to)280-286
Number of pages7
JournalRevista de Investigacion Clinica
Volume67
Issue number5
StatePublished - Sep 1 2015

Fingerprint

Idiopathic Pulmonary Fibrosis
Interstitial Lung Diseases
Rheumatoid Arthritis
Joints
Lung

Keywords

  • Citrullination
  • Idiopathic pulmonary fibrosis
  • Interstitial lung disease
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis : Shared mechanistic and phenotypic traits suggest overlapping disease mechanisms. / Paulin, Francisco; Doyle, Tracy J.; Fletcher, Elaine A.; Ascherman, Dana; Rosas, Ivan O.

In: Revista de Investigacion Clinica, Vol. 67, No. 5, 01.09.2015, p. 280-286.

Research output: Contribution to journalArticle

@article{d2013c0a3f994cdfaeef34397c6f9aa7,
title = "Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis: Shared mechanistic and phenotypic traits suggest overlapping disease mechanisms",
abstract = "The prevalence of clinically evident interstitial lung disease in patients with rheumatoid arthritis is approximately 10{\%}. An additional 33{\%} of undiagnosed patients have interstitial lung abnormalities that can be detected with high-resolution computed tomography. Rheumatoid arthritis-interstitial lung disease patients have three times the risk of death compared to those with rheumatoid arthritis occurring in the absence of interstitial lung disease, and the mortality related to interstitial lung disease is rising. Rheumatoid arthritis-interstitial lung disease is most commonly classified as the usual interstitial pneumonia pattern, overlapping mechanistically and phenotypically with idiopathic pulmonary fibrosis, but can occur in a non-usual interstitial pneumonia pattern, mainly nonspecific interstitial pneumonia. Based on this, we propose two possible pathways to explain the coexistence of rheumatoid arthritis and interstitial lung disease: (i) Rheumatoid arthritis-interstitial lung disease with a non-usual interstitial pneumonia pattern may come about when an immune response against citrullinated peptides taking place in another site (e.g. the joints) subsequently affects the lungs; (ii) Rheumatoid arthritis-interstitial lung disease with a usual interstitial pneumonia pattern may represent a disease process in which idiopathic pulmonary fibrosis-like pathology triggers an immune response against citrullinated proteins that promotes articular disease indicative of rheumatoid arthritis. More studies focused on elucidating the basic mechanisms leading to different sub-phenotypes of rheumatoid arthritis-interstitial lung disease and the overlap with idiopathic pulmonary fibrosis are necessary to improve our understanding of the disease process and to define new therapeutic targets.",
keywords = "Citrullination, Idiopathic pulmonary fibrosis, Interstitial lung disease, Rheumatoid arthritis",
author = "Francisco Paulin and Doyle, {Tracy J.} and Fletcher, {Elaine A.} and Dana Ascherman and Rosas, {Ivan O.}",
year = "2015",
month = "9",
day = "1",
language = "English (US)",
volume = "67",
pages = "280--286",
journal = "Revista de Investigacion Clinica",
issn = "0034-8376",
publisher = "Instituto Nacional de la Nutricion Salvador Zubiran",
number = "5",

}

TY - JOUR

T1 - Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis

T2 - Shared mechanistic and phenotypic traits suggest overlapping disease mechanisms

AU - Paulin, Francisco

AU - Doyle, Tracy J.

AU - Fletcher, Elaine A.

AU - Ascherman, Dana

AU - Rosas, Ivan O.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - The prevalence of clinically evident interstitial lung disease in patients with rheumatoid arthritis is approximately 10%. An additional 33% of undiagnosed patients have interstitial lung abnormalities that can be detected with high-resolution computed tomography. Rheumatoid arthritis-interstitial lung disease patients have three times the risk of death compared to those with rheumatoid arthritis occurring in the absence of interstitial lung disease, and the mortality related to interstitial lung disease is rising. Rheumatoid arthritis-interstitial lung disease is most commonly classified as the usual interstitial pneumonia pattern, overlapping mechanistically and phenotypically with idiopathic pulmonary fibrosis, but can occur in a non-usual interstitial pneumonia pattern, mainly nonspecific interstitial pneumonia. Based on this, we propose two possible pathways to explain the coexistence of rheumatoid arthritis and interstitial lung disease: (i) Rheumatoid arthritis-interstitial lung disease with a non-usual interstitial pneumonia pattern may come about when an immune response against citrullinated peptides taking place in another site (e.g. the joints) subsequently affects the lungs; (ii) Rheumatoid arthritis-interstitial lung disease with a usual interstitial pneumonia pattern may represent a disease process in which idiopathic pulmonary fibrosis-like pathology triggers an immune response against citrullinated proteins that promotes articular disease indicative of rheumatoid arthritis. More studies focused on elucidating the basic mechanisms leading to different sub-phenotypes of rheumatoid arthritis-interstitial lung disease and the overlap with idiopathic pulmonary fibrosis are necessary to improve our understanding of the disease process and to define new therapeutic targets.

AB - The prevalence of clinically evident interstitial lung disease in patients with rheumatoid arthritis is approximately 10%. An additional 33% of undiagnosed patients have interstitial lung abnormalities that can be detected with high-resolution computed tomography. Rheumatoid arthritis-interstitial lung disease patients have three times the risk of death compared to those with rheumatoid arthritis occurring in the absence of interstitial lung disease, and the mortality related to interstitial lung disease is rising. Rheumatoid arthritis-interstitial lung disease is most commonly classified as the usual interstitial pneumonia pattern, overlapping mechanistically and phenotypically with idiopathic pulmonary fibrosis, but can occur in a non-usual interstitial pneumonia pattern, mainly nonspecific interstitial pneumonia. Based on this, we propose two possible pathways to explain the coexistence of rheumatoid arthritis and interstitial lung disease: (i) Rheumatoid arthritis-interstitial lung disease with a non-usual interstitial pneumonia pattern may come about when an immune response against citrullinated peptides taking place in another site (e.g. the joints) subsequently affects the lungs; (ii) Rheumatoid arthritis-interstitial lung disease with a usual interstitial pneumonia pattern may represent a disease process in which idiopathic pulmonary fibrosis-like pathology triggers an immune response against citrullinated proteins that promotes articular disease indicative of rheumatoid arthritis. More studies focused on elucidating the basic mechanisms leading to different sub-phenotypes of rheumatoid arthritis-interstitial lung disease and the overlap with idiopathic pulmonary fibrosis are necessary to improve our understanding of the disease process and to define new therapeutic targets.

KW - Citrullination

KW - Idiopathic pulmonary fibrosis

KW - Interstitial lung disease

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84960851170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960851170&partnerID=8YFLogxK

M3 - Article

VL - 67

SP - 280

EP - 286

JO - Revista de Investigacion Clinica

JF - Revista de Investigacion Clinica

SN - 0034-8376

IS - 5

ER -